120
Participants
Start Date
April 11, 2023
Primary Completion Date
December 15, 2025
Study Completion Date
December 15, 2025
Cannabidiol
The current study will directly test the hypothesis that a moderate dose of CBD leads to improvements in cognition, TBI-related symptoms, pain, sleep, depression, anxiety, and peripheral markers of inflammation and oxidative stress.
Placebo
Placebo arm
RECRUITING
University of Colorado Anschutz, Aurora
Colorado State University
OTHER
University of Colorado, Denver
OTHER